Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Instafamous Dr. Simon Ourian and Epione Medical Corporation Sued by Dr. Adam Rubinstein for Alleged Fraud, Defamation and Slander

Dr. Adam J. Rubinstein, M.D. FACS has filed a multimillion dollar lawsuit against Dr. Simon Ourian M.D. and Epione Medical Corporation in Beverly Hills. The lawsuit alleges that Dr. Ourian orchestrated a retaliatory and fraudulent scheme to maliciously defame and slander Dr. Rubinstein's personal and professional character by creating hundreds of false and misleading posts about Dr. Rubinstein.


News provided by

Adam J. Rubinstein, MD, FACS

May 20, 2020, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Adam J. Rubinstein, M.D. FACS
Dr. Adam J. Rubinstein, M.D. FACS

MIAMI, May 20, 2020 /PRNewswire-PRWeb/ -- Award winning and highly renowned, board certified Miami based plastic surgeon, Dr. Adam J. Rubinstein, M.D. FACS has filed a multimillion dollar lawsuit against Dr. Simon Ourian M.D. and Epione Medical Corporation in Beverly Hills. The suit alleges multiple charges against Dr. Simon Ourian including among them Defamation and Slander, Libel, and Fraud. The case is filed in US District Court for the Southern District of Florida (case #1:2020cv21948) and is being handled by The Ferrarro Law Firm ("Ferraro Law") in Miami, Florida with the legal team of James L. Ferraro, Esq and Janpaul Portal Esq.

The lawsuit alleges that Dr. Ourian orchestrated a retaliatory and fraudulent scheme to maliciously defame and slander Dr. Rubinstein's personal and professional character by creating hundreds of false and misleading posts about Dr. Rubinstein. This was allegedly accomplished via fictitious patient reviews from multiple websites, including, but not limited to, Google, RateMDs, Vitals, Ripoff Report, Yelp, and similar online outlets. The fake reviews are alleged to be in retaliation for videos made about Dr. Ourian by Dr. Rubinstein.

“I am dedicated to sharing the truth with the public no matter how shocking it may be,” says Dr Adam J Rubinstein.

Post this

The complaint alleges the fake negative reviews were created and posted on multiple websites and social media platforms by Dr. Ourian, directly and/or through his agents. The suit describes the alleged hiring of foreign operatives that were directed and/or acted on behalf of Dr. Ourian. In some instances, the suit claims, Dr. Ourian allegedly directed his operatives to post fake positive reviews about himself at or about the same time they were directed to post fake negative reviews about Dr. Rubinstein on the same internet sites.

Dr. Rubinstein, a committed advocate for patients safety, truth and transparency in the aesthetics industry, frequently posts about doctors that are not revealing the full truth about themselves. His series of videos entitled, "Exposed" is dedicated to shining light on misleading or otherwise deceptive practices. He has also worked with local and national media to expose the truth about disingenuous doctors.

"I am dedicated to sharing the truth with the public no matter how shocking it may be," says Dr Adam J Rubinstein. "Sometimes the truth is not pleasant or complimentary. It is still, however, the truth. If I find myself being victimized for doing the right thing for patients, I have to defend myself to the fullest extent of the law."

The Ferraro Law Firm on behalf of Dr Rubinstein brings this action to recover damages he has incurred or will incur as a result of the alleged Dr Ourian tortious conduct and as well as investigating, reporting and removing these fake posts from multiple websites, including, but not limited to, Google, RateMDs, Vitals, Ripoff Report, Yelp, and similar social media places.

"In cases of online defamation and, unfortunately, many people do not realize the pervasive damage that is being done to people's reputations online." says James L. Ferraro Esq. "This is serious business."
About Dr Adam J. Rubinstein
Dr Adam J. Rubinstein is a board certified and award winning plastic surgeon. He has served as the Chief of Plastic Surgery and Chief of the Department of Surgery for Jackson North Medical Center in Miami, FL. Dr Rubinstein specializes in whole body surgical & non-surgical cosmetic treatments for both women and men. He can discuss the latest innovations and procedures to help people make proper and informed choices. Dr. Rubinstein is also a patient advocate and is passionate about sharing the good, the bad and the ugly about common plastic surgery practices to help patients navigate the world of plastic surgery effectively and safely. His goal is to help people make their best choices about the latest and most innovative procedures. He believes people have the right to know the truth to make informed choices. You can learn more on his social channels including his website http://www.dr-rubinstein.com, Instagram accounts, @drrubinstein and @plasticsurgerytruths, SnapChat @drrubinstein, and Facebook page @MiamiPlasticSurgeon.
In addition, Dr. Rubinstein is an active member of many prestigious medical societies and associations, including, but not limited to: The American Society of Plastic Surgeons; The American Society for Aesthetic Plastic Surgery; The International Society of Aesthetic Plastic Surgery; The American Academy of Anti-Aging Medicine; and The Ralph Millard Jr., M.D., Medical Society and Education Foundation. Dr. Rubinstein is also a founding member of the American Society of Bariatric Plastic Surgeons. He has also served on the editorial staff of the Aesthetic Plastic Surgery Journal published by the International Society of Aesthetic Plastic Surgery

About The Ferraro Law Firm
Ferraro Law has over three decades of experience in commercial and mass tort litigation representing thousands of clients in complex commercial litigation, asbestos, tobacco, environmental, and pharmaceutical/defective drug cases. Ferraro Law is headquartered in Miami, Florida and has a significant presence nationwide. Ferraro Law has earned its place as one of the top five firms in the United States in the areas of product liability, asbestos and environmental toxic tort lawsuits. Ferraro Law also has a strong track record in the Florida District Courts of Appeal and Florida Supreme Court. Over the past five years, Ferraro Law has won several multi-million-dollar verdicts for its clients.

Jim Ferraro would serve as the lead attorney for Ferraro Law, and is both nationally and locally recognized for his trial advocacy in complex tort cases. Jim has successfully tried many cases that resulted in multi-million dollar jury verdicts. Jim has negotiated settlements in the billions of dollars on behalf of tens of thousands of clients in his years of practice. In 1996, Jim made American legal history when he successfully tried a case against DuPont in the first case against a chemical company for causing a birth defect. Jim proved that a pregnant woman's exposure to the fungicide Benlate caused her child to be born without eyes and held DuPont accountable in Castillo vs. E.I. du Pont de Nemours and Company and Pine Island Farms. The trial was broadcast in its entirety on Court TV, garnered worldwide media attention and, ultimately, went to the Florida Supreme Court. Seven years after trial, the Supreme Court of Florida affirmed the trial court verdict. In 1997, because of that case, Jim was named one of ten national finalists for Trial Lawyer of the Year. The Castillo case is now featured in Mr. Ferraro's 2017 bestselling book, Blindsided.

SOURCE Adam J. Rubinstein, MD, FACS

Related Links

https://www.dr-rubinstein.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.